Newamsterdam Pharma Company Nv (NAMS) Technical Analysis
$37.08▲0.08%
Insights
- Newamsterdam Pharma Company Nv is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Newamsterdam Pharma Company Nv stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Newamsterdam Pharma Company Nv stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Newamsterdam Pharma Company Nv stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 81.86 | Sell |
Stochastic | 99.82, 87.34 | Neutral |
Ultimate Oscillator | 77.56 | Sell |
Stochastic Relative Strength Index | 99.72, 97.6 | Neutral |
Moving Average Convergence Divergence | 2.37, 1.66 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 31.43 | Buy |
20 | 28.81 | Buy |
50 | 26.31 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 31.96 | Buy |
20 | 29.87 | Buy |
50 | 26.9 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 31.61 | Buy |
20 | 29.52 | Buy |
50 | 26.77 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 34.56 | Buy |
20 | 32.81 | Buy |
50 | 30.31 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 35.47 | Buy |
20 | 34.14 | Buy |
50 | 31.72 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 35.02 |
Resistance L2 | 34.03 |
Resistance L1 | 33.52 |
Pivot Point | 32.53 |
Support L1 | 32.02 |
Support L2 | 31.03 |
Support L3 | 30.52 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.